Search
Powered By HealthLine
Special Offers
TV Specials
 Learn about an Effective Alzheimer's Medication
 Bipolar Education Health Center
 Osteoarthritis of the Knee Solution Center
 Heartburn Education Center
 Breast Cancer Health Center
 Crohn's Disease Health Center
 Schizophrenia Education Center
Top Features
 Depression
 Schizophrenia
 Breast Cancer
 Bipolar
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Stimulating Occipital Nerve Eases Cluster Headaches

But the pain returns once the experimental therapy is stopped, studies find

By Amanda Gardner
HealthDay Reporter


Related Healthscout Videos
 border=
Detecting Restless Legs
Implant For Headaches
Healing Migraines ... Naturally
Treating Migraines with Botox?
More...

Related Animations
 border=
Migraine
More...

Related News Articles
 border=
Health Tip: Muscle Injury?
Health Tip: What's Behind My Migraine?
Health Tip: Don't Get Burned by Hot Water
Taking Multiple Pain Relievers May Cause Complications
More...

THURSDAY, March 8 (HealthDay News) -- Two pilot studies found that electrical stimulation of the occipital nerve helped ease the agony of cluster headaches, which some have likened to getting stuck in the eye with a hot poker.

The studies, which involved eight patients each, were published in this week's The Lancet and The Lancet Neurology.

Text Continues Below



"These studies concord to indicate that ONS (occipital nerve stimulation) is a clinically useful treatment in drug-resistant chronic cluster headache, and that it should receive a trial before hypothalamic deep brain stimulation which is also effective but not risk-less," said Dr. Jean Schoenen, author of the Lancet Neurology study and professor of neurology at Liege University in Liege, Belgium.

Previous trials of hypothalamic deep brain stimulation, which involves stimulating the hypothalamus region of the brain, showed a small risk of fatal hemorrhage.

Other experts urged caution when interpreting the new findings.

"You cannot generalize from two studies of eight people to the whole universe, but one would certainly call it very encouraging," said Dr. Jay Selman, a neurologist with Northern Westchester Hospital Center in Mount Kisco, N.Y., and clinical associate professor of neurology at Columbia University in New York City. "There were no significant side effects, no unintended consequences," Selman added.

Cluster headaches are much less common than migraines, affecting about one in 1,000 people. They typically strike in clusters once or twice a year, causing attacks one or two times a day for two to three months. The debilitating attacks last for about two hours and affect one side of the head.

"In the world of headaches, cluster headaches are much less common than tension-type headaches or migraines but are very severe and can be incredibly debilitating to patients," Selman explained. "Within the world of cluster headaches, there is a small group who have chronic cluster headaches, meaning they don't go more than about a month or so without attack. This subgroup is very difficult to manage. The problem is that they have ended up being on a variety of medications, often multiple medications, which don't tend to work well."

Page:  1 | 2 | 3 | Next >>

Copyright © 2007 ScoutNews, LLC. All rights reserved.
Last updated 3/8/2007

Related Links
 border=
From Healthscout's partner site on migraine, MyMigraineConnection.com
FAQ: Answers to the top 75 migraine and headache questions
DRUGS: Common drugs used to treat migraines
TREATMENT: Lifestyle changes can make migraines more bearable





New Features

New ADHD Site!

SOURCES: Jean Schoenen, M.D., Ph.D., professor of neurology, Liege University, Liege, Belgium; Peter J. Goadsby, M.D., professor, Institute of Neurology, National Hospital for Neurology & Neurosurgery, London, England; Jay Selman, M.D., neurologist, Northern Westchester Hospital Center, Mount Kisco, N.Y., and clinical associate professor of neurology, Columbia University, New York City; March 8, 2007, The Lancet and The Lancet Neurology, online


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map